Knockdown of mesenchymal stem cell-derived exosomal LOC100129516 suppresses the symptoms of atherosclerosis via upregulation of the PPARγ/LXRα/ABCA1 signaling pathway

Mostrar otras versiones (1)

Mesenchymal stem cell (MSC) therapy has potential applications in treating atherosclerosis and coronary heart disease (CAD). Previous studies have demonstrated that MSCs are the most preferable sources of therapeutic exosomes, which carry long non-coding RNAs and participate in the progression of at...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Limin, He, Xin, Zhang, Tao, Han, Yaling, Tao, Guizhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8510681/
https://www.ncbi.nlm.nih.gov/pubmed/34608501
http://dx.doi.org/10.3892/ijmm.2021.5041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8510681/
https://www.ncbi.nlm.nih.gov/pubmed/34608501
http://dx.doi.org/10.3892/ijmm.2021.5041

Ejemplares similares